Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review

SIMPLE SUMMARY: Around 30–60% of the patients with lung cancer develop bone metastases, which are associated with decreased survival, bone pain, and skeletal-related events such as need for radiation. Patients with an epidermal growth factor mutation (EGFR), a subgroup of the patients with lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouns, Anita, Dursun, Safiye, Bootsma, Gerben, Dingemans, Anne-Marie C., Hendriks, Lizza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267949/
https://www.ncbi.nlm.nih.gov/pubmed/34201833
http://dx.doi.org/10.3390/cancers13133144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267949/
https://www.ncbi.nlm.nih.gov/pubmed/34201833
http://dx.doi.org/10.3390/cancers13133144

Ejemplares similares